Investor Relations

Partnerships are integral to Harbour BioMed's strategy to build a fully integrated biopharmaceutical company.

  1. Mar 29, 2023

    2022 Annual Results Online Conference

  2. Dec 12, 2022

    2022 Investor Day

  3. Aug 31, 2022

    2022 Interim Results Online Conference

  4. Apr 09, 2022

    HBM7022 Out-license to AstraZeneca

  5. Mar 25, 2022

    2021 Annual Results Online Conference